Quality-of-care performance means more to CEO paychecks at some for-profit hospital companies than at others.
Quality-of-care performance means more to CEO paychecks at some for-profit hospital companies than at others.
Among the five largest publicly traded systems, Tenet Healthcare Corp. and HCA go farthest in tying executive pay to quality-of-care measures. Still, use of quality incentives—the cash awards that companies reserve for top operational and strategic priorities and that can double an executive's salary—is uneven. At systems that explicitly pay executives based on quality, the weight given to incentives varies from 15% to 25%. Measures of performance used range from those indirectly related to quality, such as employee turnover, to those widely acknowledged as central, such as rates of fatal healthcare-associated infections.
But for an industry plagued with inconsistent patient safety and outcomes, healthcare has been slow to focus top executives' attention on quality by using performance-pay incentives. This is evident in compensation of the publicly traded health systems, which operate 1 in 10 U.S. hospitals and saw 3.8 million admissions last year.
Read the full story here: http://bit.ly/1hHfYJg
Source: Modern Healthcare
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen